Nashat Amir
CIK 0001575843 Name as filed on the most recent filing
Filed as Nashat Amir (34)
150 transaction lines · from 34 filings · filed 2013-05-14 to 2025-09-11 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
- ISSUER Camp4 Therapeutics Corp 2 filings
- ISSUER Scholar Rock Holding Corp 2 filings
- ISSUER Morphic Holding, Inc. 2 filings
- ISSUER Metacrine, Inc. 1 filings
- ISSUER Fate Therapeutics Inc 15 filings
- ISSUER Selecta Biosciences Inc 5 filings
- ISSUER Syros Pharmaceuticals, Inc. 1 filings
- ISSUER Receptos, Inc. 6 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
150 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2025-09-11 |
Camp4 Therapeutics Corp CAMP |
P, Open-market purchase | 1,221,721 acquired | 1.53 | 1,869,233.13 | Form 4, filing 0001193125-25-201380 | |
| 2025-09-11 |
Camp4 Therapeutics Corp CAMP |
P, Open-market purchase | 85,468 acquired | 1.53 | 130,766.04 | Form 4, filing 0001193125-25-201380 | |
| 2024-10-15 |
Camp4 Therapeutics Corp CAMP |
P, Open-market purchase | 909,090 acquired | 11.00 | 9,999,990.00 | Form 4, filing 0001104659-24-108703 | |
| 2022-06-22 |
Scholar Rock Holding Corp SRRK |
P, Open-market purchase | 1,131,850 acquired | 4.90 | 5,546,065.00 | Form 4, filing 0000899243-22-023965 | |
| 2022-06-22 |
Scholar Rock Holding Corp SRRK |
P, Open-market purchase | 66,142 acquired | 4.90 | 324,095.80 | Form 4, filing 0000899243-22-023965 | |
| 2021-05-21 |
Morphic Holding, Inc. MORF |
S, Open-market sale | 217,107 disposed | 45.50 | 9,878,368.50 | Form 4, filing 0000899243-21-020599 | |
| 2021-05-21 |
Morphic Holding, Inc. MORF |
S, Open-market sale | 15,188 disposed | 45.50 | 691,054.00 | Form 4, filing 0000899243-21-020599 | |
| 2020-09-18 |
Metacrine, Inc. MTCR |
P, Open-market purchase | 214,962 acquired | 13.00 | 2,794,506.00 | Form 4, filing 0001209191-20-051504 | |
| 2020-09-18 |
Metacrine, Inc. MTCR |
P, Open-market purchase | 15,038 acquired | 13.00 | 195,494.00 | Form 4, filing 0001209191-20-051504 | |
| 2019-08-01 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 29,782 disposed | 22.53 | 670,970.59 | Form 4, filing 0000899243-19-020915 | |
| 2019-08-01 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 581 disposed | 22.53 | 13,089.58 | Form 4, filing 0000899243-19-020915 | |
| 2019-08-01 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 299 disposed | 22.53 | 6,736.32 | Form 4, filing 0000899243-19-020915 | |
| 2019-08-01 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 204 disposed | 22.53 | 4,596.00 | Form 4, filing 0000899243-19-020915 | |
| 2019-07-31 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 30,045 disposed | 22.53 | 677,022.01 | Form 4, filing 0000899243-19-020915 | |
| 2019-07-31 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 586 disposed | 22.53 | 13,204.63 | Form 4, filing 0000899243-19-020915 | |
| 2019-07-31 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 302 disposed | 22.53 | 6,805.18 | Form 4, filing 0000899243-19-020915 | |
| 2019-07-31 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 206 disposed | 22.53 | 4,641.98 | Form 4, filing 0000899243-19-020915 | |
| 2019-07-30 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 87,010 disposed | 22.51 | 1,958,325.37 | Form 4, filing 0000899243-19-020605 | |
| 2019-07-30 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 1,696 disposed | 22.51 | 38,171.70 | Form 4, filing 0000899243-19-020605 | |
| 2019-07-30 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 873 disposed | 22.51 | 19,648.52 | Form 4, filing 0000899243-19-020605 | |
| 2019-07-30 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 596 disposed | 22.51 | 13,414.11 | Form 4, filing 0000899243-19-020605 | |
| 2019-07-29 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 317 disposed | 22.50 | 7,132.50 | Form 4, filing 0000899243-19-020605 | |
| 2019-07-29 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 6 disposed | 22.50 | 135.00 | Form 4, filing 0000899243-19-020605 | |
| 2019-07-29 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 3 disposed | 22.50 | 67.50 | Form 4, filing 0000899243-19-020605 | |
| 2019-07-29 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 3 disposed | 22.50 | 67.50 | Form 4, filing 0000899243-19-020605 | |
| 2019-07-26 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 26,852 disposed | 22.50 | 604,170.00 | Form 4, filing 0000899243-19-020605 | |
| 2019-07-26 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 523 disposed | 22.50 | 11,767.50 | Form 4, filing 0000899243-19-020605 | |
| 2019-07-26 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 270 disposed | 22.50 | 6,075.03 | Form 4, filing 0000899243-19-020605 | |
| 2019-07-26 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 184 disposed | 22.50 | 4,140.00 | Form 4, filing 0000899243-19-020605 | |
| 2019-07-24 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 19,168 disposed | 22.51 | 431,389.26 | Form 4, filing 0000899243-19-020426 | |
| 2019-07-24 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 374 disposed | 22.51 | 8,417.13 | Form 4, filing 0000899243-19-020426 | |
| 2019-07-24 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 192 disposed | 22.51 | 4,321.09 | Form 4, filing 0000899243-19-020426 | |
| 2019-07-24 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 132 disposed | 22.51 | 2,970.77 | Form 4, filing 0000899243-19-020426 | |
| 2019-07-23 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 59,854 disposed | 22.50 | 1,347,014.27 | Form 4, filing 0000899243-19-020426 | |
| 2019-07-23 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 1,167 disposed | 22.50 | 26,263.34 | Form 4, filing 0000899243-19-020426 | |
| 2019-07-23 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 601 disposed | 22.50 | 13,525.50 | Form 4, filing 0000899243-19-020426 | |
| 2019-07-23 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 411 disposed | 22.51 | 9,249.60 | Form 4, filing 0000899243-19-020426 | |
| 2019-07-22 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 46,992 disposed | 22.52 | 1,058,457.21 | Form 4, filing 0000899243-19-020033 | |
| 2019-07-22 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 917 disposed | 22.52 | 20,654.69 | Form 4, filing 0000899243-19-020033 | |
| 2019-07-22 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 472 disposed | 22.52 | 10,631.38 | Form 4, filing 0000899243-19-020033 | |
| 2019-07-22 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 323 disposed | 22.52 | 7,275.35 | Form 4, filing 0000899243-19-020033 | |
| 2019-07-19 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 1,016 disposed | 22.50 | 22,860.00 | Form 4, filing 0000899243-19-020033 | |
| 2019-07-19 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 20 disposed | 22.50 | 450.00 | Form 4, filing 0000899243-19-020033 | |
| 2019-07-19 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 10 disposed | 22.50 | 225.00 | Form 4, filing 0000899243-19-020033 | |
| 2019-07-19 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 7 disposed | 22.50 | 157.50 | Form 4, filing 0000899243-19-020033 | |
| 2019-07-18 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 20,656 disposed | 22.50 | 464,848.82 | Form 4, filing 0000899243-19-020033 | |
| 2019-07-18 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 403 disposed | 22.50 | 9,069.19 | Form 4, filing 0000899243-19-020033 | |
| 2019-07-18 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 208 disposed | 22.50 | 4,680.92 | Form 4, filing 0000899243-19-020033 | |
| 2019-07-18 |
Fate Therapeutics Inc FATE |
S, Open-market sale | 142 disposed | 22.50 | 3,195.61 | Form 4, filing 0000899243-19-020033 | |
| 2019-07-01 |
Morphic Holding, Inc. MORF |
P, Open-market purchase | 116,827 acquired | 15.00 | 1,752,405.00 | Form 4, filing 0001179110-19-008259 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 26
- Open-market sale 124
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Nashat Amir, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001575843
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6